NeoCura Bio-Medical Technology Co., Ltd.

Founded in 2017, NeoCura Bio-Medical Technology Co., Ltd. (“NeoCura” for short) is committed to building an global leading RNA innovative drug platform. It has built multi-omics big data collection platform and multi-biomics database to perform in-dcpth drug target mining and fully automated drug design based on AI algorithm and core bioinformatic technologies. Through application in clinical innovative RNA drugs development and next-generation, safe, and efficient clinical precision diagnosis and treatment, NeoCura provides patients with one-stop full-cycle sulution from screening, diagnosis, treatment to efficacy monitoring.